This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now

This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now

The bad news is Moderna's vaccine may not be able to replicate these levels in a post-pandemic environment. The good news is the vaccine still could lead to significant blockbuster revenue -- and that will support the development of Moderna's late-stage pipeline. As a result, Moderna could launch other potential blockbusters over the next few years.